Abstract
BackgroundAnabolic androgenic steroids (AAS) usage is widespread and increasing. AAS drug-induced liver injury (DILI) is recognised but its clinical course and management is poorly described. We report 2 cases of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have